Hologic to Webcast Presentation at the 23rd Annual Morgan Stanley Global Healthcare Conference

Hologic to Webcast Presentation at the 23rd Annual Morgan Stanley Global Healthcare Conference

Hologic, Inc. (Nasdaq: HOLX) announced today that the Company will present at the 23 rd Annual Morgan Stanley Global Healthcare Conference in New York at 10:45 a.m. Eastern Time on Tuesday, September 9 th .

The fireside chat presentation will be webcast live and may be accessed through a link on the investors section of Hologic's website at http://investors.hologic.com . The webcast will be available for 30 days following the event.

About Hologic, Inc.

Hologic, Inc. is an innovative medical technology company primarily focused on improving women's health and well-being through early detection and treatment. For more information on Hologic, visit www.hologic.com .

SOURCE: Hologic, Inc.

Paula Izidoro
Manager, Investor Relations and Social Media
(858) 410-8904
paula.izidoro@hologic.com

News Provided by Business Wire via QuoteMedia

HOLX
The Conversation (0)
Hologic

Hologic

Hologic manufactures proprietary products for the healthcare needs of women. The company operates in five segments: diagnostics (64% of total sales, boosted by pandemic), breast health (21% of sales, suppressed by pandemic), surgical (12%), and skeletal health (2%). While the company traditionally focused on breast health, the acquisition of Gen-Probe put greater emphasis on commercial diagnostics. The United States accounts for the largest portion of the firm's revenue (75%), followed by Europe (16%), Asia (6%), and other international markets (3%). Hologic is headquartered in Bedford, Massachusetts.

Latest Press Releases

Related News

×